Please login to the form below

Not currently logged in
Email:
Password:

Ceuta Holdings acquires Creative Leap

The comms agency will continue to act as an independent business

Creative LeapCeuta Holdings, a consumer brand services organisation has acquired brand and communications agency Creative Leap.

Founded in 1996, Creative Leap is an integrated service that has a strong expertise in OTC, VMS and the personal care sectors.

David Gray, chief executive officer at Creative Leap, said: “We have successfully collaborated with Ceuta on a number of occasions in the last couple of years and have been impressed by their experience and professionalism.

“We are very excited to join Ceuta Group to deepen our collaboration and better serve the needs of our clients both in the UK and overseas.”

As part of the deal, Creative Leap will continue to operate as an independent business but will work closely with the other companies across Ceuta Group to collectively support and drive ‘outstanding’ results for their brands and clients.

Edwin Bessant, chief executive officer for Ceuta Group, said: “We are delighted to welcome Creative Leap to the Ceuta Group family.

“They are a highly respected business with a reputation for delivering exceptional results for their clients.

“Creative Leap will complement our integrated platform of services; allowing us to deliver additional value to our clients globally through their insight, expertise and deep understanding of the industry.”

Article by
Gemma Jones

6th September 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...